Lack of interaction between ErbB2 and insulin receptor substrate signaling in breast cancer

被引：0
|
作者：
Susan M. Farabaugh
Bonita T. Chan
Xiaojiang Cui
Robert K. Dearth
Adrian V. Lee
机构：
[1] University of Pittsburgh Cancer Institute,Women’s Cancer Research Center, Department of Pharmacology and Chemical Biology
[2] Magee Women’s Research Institute,Lester and Sue Smith Breast Center, Department of Molecular and Cellular Biology
[3] Baylor College of Medicine,undefined
来源：
Cell Communication and Signaling | / 14卷
关键词：
IRS; ErbB2; Breast cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Novel insulin receptor substrate 1 and 2 variants in breast and colorectal cancer
    Esposito, Diana Liberata
    Verginelli, Fabio
    Toracchio, Sonia
    Mammarella, Sandra
    De Lellis, Laura
    Vanni, Cinzia
    Russo, Antonio
    Mariani-Costantini, Renato
    Cama, Alessandro
    ONCOLOGY REPORTS, 2013, 30 (04) : 1553 - 1560
  • [42] Hormone receptor status, erbB2 expression and cancer stem cell characteristics of circulating tumor cells in breast cancer patients
    Rack, Brigitte
    Bock, Carolin
    Andergassen, Ulrich
    Doisneau-Sixou, Sophie
    HISTOLOGY AND HISTOPATHOLOGY, 2012, 27 (07) : 855 - 864
  • [43] Regulation of ErbB2 localization and function in breast cancer cells by ERM proteins
    Asp, Nagham
    Kvalvaag, Audun
    Sandvig, Kirsten
    Pust, Sascha
    ONCOTARGET, 2016, 7 (18) : 25443 - 25460
  • [44] ErbB2 down-regulates microRNA-205 in breast cancer
    Adachi, Ryohei
    Horiuchi, Shota
    Sakurazawa, Yoshiyuki
    Hasegawa, Takuya
    Sato, Koji
    Sakamaki, Toshiyuki
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2011, 411 (04) : 804 - 808
  • [45] INT2 and ERBB2 amplification and ERBB2 expression in breast tumors from patients with different outcomes
    Pauley, RJ
    Gimotty, PA
    Paine, TJ
    Dawson, PJ
    Wolman, SR
    BREAST CANCER RESEARCH AND TREATMENT, 1996, 37 (01) : 65 - 76
  • [46] Current trends in ERBB2 activation assessment in breast cancer. ERBB2-based anticancer strategies
    Tse, C
    Brault, D
    Etienne, J
    ANNALES DE BIOLOGIE CLINIQUE, 1997, 55 (06) : 545 - 554
  • [47] Progesterone crosstalks with insulin-like growth factor signaling in breast cancer cells via induction of insulin receptor substrate-2
    Xiaojiang Cui
    ZaWaunyka Lazard
    Ping Zhang
    Torsten A Hopp
    Adrian V Lee
    Oncogene, 2003, 22 : 6937 - 6941
  • [48] Progesterone crosstalks with insulin-like growth factor signaling in breast cancer cells via induction of insulin receptor substrate-2
    Cui, XJ
    Lazard, Z
    Zhang, P
    Hopp, TA
    Lee, AV
    ONCOGENE, 2003, 22 (44) : 6937 - 6941
  • [49] Cofactor competition between the ligand-bound oestrogen receptor and an intron 1 enhancer leads to oestrogen repression of ERBB2 expression in breast cancer
    Newman, SP
    Bates, NP
    Vernimmen, D
    Parker, MG
    Hurst, HC
    ONCOGENE, 2000, 19 (04) : 490 - 497
  • [50] Cofactor competition between the ligand-bound oestrogen receptor and an intron 1 enhancer leads to oestrogen repression of ERBB2 expression in breast cancer
    Simon P Newman
    Nicholas P Bates
    Douglas Vernimmen
    Malcolm G Parker
    Helen C Hurst
    Oncogene, 2000, 19 : 490 - 497
12345